
Avanti Feeds Q3 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- Shrimp feed volumes are expected to grow modestly, around 5% to 10% year-on-year, influenced by stable area of culture, market prices, and climatic conditions. (Page 19)
- The first crop production for 2025 is anticipated to be stable or slightly better than 2024 with good farmgate and feed prices. (Page 24)
- Pet food and fish feed are identified as future growth drivers, with the pet food market in India growing at approximately 20% CAGR. (Pages 20, 12)
- Shrimp processing is focusing on increasing value-added products and expanding exports beyond the U.S. to markets such as Europe, Middle East, Japan, and Korea. (Pages 9, 21)
- Exports in the shrimp feed business are currently low (1%-2%) but expected to increase, especially towards the Middle East and Bangladesh. (Page 14)
- The company plans to scale up production capacities, including a pet food plant expected to commence production by December 2026. (Pages 10, 9)
See what Avanti Feeds management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No explicit mention of any current or planned fundraising through debt or equity in the transcript.
- Discussions focused on project preparations, machinery imports, and investments in pet food and fish feed plants.
- Investment in pet food plant expected to begin after trials and market testing, with production targeted by end of 2026.
- Investment decisions for fish feed plant contingent on trial results and market assessment.
- No formal investment proposal or fundraising details are disclosed at this stage.
- Cost optimization and focus on higher value products to improve margins are highlighted, but no fundraising indicated.
See what Avanti Feeds management said on order book — free account, 30 seconds.
Capex plans
Yes- Land for pet food plant purchased near Hyderabad (~30 acres) with INR 36 crores spent.
- Planned capex for pet food plant machinery around INR 60 crores.
- Pet food manufacturing facility expected to start commercial production by December 2026.
- Currently importing pet food from Thailand while testing market acceptance and feed adaptability.
- Planning and consultancy with Bluefalo Limited Thailand ongoing for plant design, machinery, and civil works.
- Capex details and project cost projections expected to be finalized in 3-4 months post-survey and planning.
- Focus on optimizing costs and expanding into value-added shrimp products, new markets beyond the US.
- Testing fish feed for various species underway; investment decision pending after trial results and market analysis.
- Export growth initiatives ongoing for shrimp feed to Middle East and Bangladesh; current feed export at 1-2%.
Track Avanti Feeds — get its next earnings analysis in your feed
How does Avanti Feeds rank vs peers in Food Products?
Pro featureHow does Avanti Feeds rank in Food Products?
Compare Avanti Feeds against every Food Products company (Q3 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Avanti Feeds's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Food Products this season
- Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.